Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent Hepatitis C

American Journal of Transplantation

Volumn 9, Issue 3, 2009, Pages 601-609

  Rigamonti, C ^a,b   Vidali, M ^b   Donato, M F ^a   Sutti, S ^b   Occhino, G ^b   Ivaldi, A ^b   Arosio, E ^a   Agnelli, F ^a   Rossi, G ^a   Colombo, M ^a   Albano, E ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Autoantibodies; Autoimmunity; Liver biopsy; Liver transplantation; Recurrent hepatitis C

Indexed keywords

AUTOANTIBODY; CYTOCHROME P450 2E1; CYTOCHROME P450 2E1 ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RECURRENT INFECTION;

AUTOANTIBODIES; CYTOCHROME P-450 CYP2E1; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MALE; NECROSIS; RECURRENCE; RISK FACTORS;

EID: 60649106618     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02520.x     Document Type: Article

References (42)

1. Berenguer M. What determines the natural history of recurrent hepatitis C after liver transplantation J Hepatol 2005 42 : 448 456.
2. Berenguer M, Prieto M, Rayón JM et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000 32 (4 Pt 1 852 858.
3. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002 122 : 889 896.
4. Lake JR. The role of immunosuppression in recurrence of hepatitis C. Liver Transpl 2003 9 : S63 S66.
5. Féray C, Gigou M, Samuel D et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995 108 : 1088 1096.
6. Guido M, Fagiuoli S, Tessari G et al. Histology predicts cirrhotic evolution of posttransplant hepatitis C. Gut 2002 50 : 697 700.
7. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002 36 : 202 210. Erratum in: Hepatology 2003; 37: 489.
8. Ghany MG, Kleiner DE, Alter H et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003 124 : 97 104.
9. Belli LS, Burra P, Poli F et al. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation. Gastroenterology 2006 130 : 695 702.
10. Vergani D, Mieli-Vergani G. Autoimmunity after liver transplantation. Hepatology 2002 36 : 271 276.
11. Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002 8 : 505 513.
12. Evans HM, Kelly DA, McKierman PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006 43 : 1109 1117.
13. Lytton SD, Berg U, Nemeth A, Ingelman-Sundberg H. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. Clin Exp Immunol 2002 127 : 293 302.
14. Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: Model autoantigens to study drug-induced, virus-induced and autoimmune liver disease. Hepatology 1997 26 : 1054 1066.
15. Boitier E, Beaune P. Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update. Clin Rev Allergy Immunol 2000 18 : 215 239.
16. Vidali M, Occhino G, Ivaldi A et al. Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C. J Hepatol 2007 46 : 605 612.
17. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992 16 : 865 876.
18. Banff Working Group. Demetris AJ, Adeyi O, Bellamy CO et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006 44 : 489 501.
19. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 699.
20. An international panel comprised of Demetris AJ, Batts KP, Dhillon AP et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997 25 : 658 663.
21. Demetris AJ, Eghtesad B, Marcos A et al. Recurrent hepatitis C in liver allografts: Prospective assessment of diagnostic accuracy, identification of pitfalls and observations about pathogenesis. Am J Surg Pathol 2004 28 : 658 669.
22. Vidali M, Stewart SF, Rolla R et al. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 2003 37 : 410 419.
23. Strassburg CP, Vogel A, Manns MP. Autoimmunity and hepatitis C. Autoimmun Rev 2003 2 : 322 331.
24. Vergani D, Mieli-Vergani G. The impact of autoimmunity on hepatocytes. Sem Liver Dis 2007 27 : 140 151.
25. Khettry U, Huang WY, Simpson MA et al. Patterns of recurrent hepatitis C after liver transplantation in recent cohort of patients. Hum Pathol 2007 38 : 443 452.
26. Fiel MI, Agarwal K, Stanca C et al. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to negative outcome in patients with hepatitis C virus. Liver Transpl 2008 14 : 861 871.
27. Loeper J, Descatoire V, Maurice M et al. Cytochrome P450 in human hepatocyte plasma membrane: Recognition by several autoantibodies. Gastroenterology 1993 104 : 203 216.
28. Neve EP, Eliasson E, Pronzato MA, Albano E, Marinari U, Ingelman-Sundberg M. Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus. Arch Biochem Biophys 1996 333 : 459 465.
29. Eliasson E, Kenna JG. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol Pharmacol 1996 50 : 573 582.
30. Ma Y, Bogdanos DP, Hussain MJ et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis C. Gastroenterology 2006 130 : 868 882.
31. Longhi MS, Hussain MJ, Bogdanos DP et al. Cytochrome P450IID6-specific CD8 T-cell immune responses minor disease activity in autoimmune hepatitis C type 2. Hepatology 2007 46 : 472 484.
32. Machicao VI, Bonatti H, Krishna M et al. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004 77 : 84 92.
33. Sheiner PA, Schwartz ME, Mor E et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995 21 : 30 34.
34. Bourdi M, Chen W, Peter RM et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chem Res Toxicol 1996 9 : 1159 1166.
35. Hoet P, Graf ML, Bourdi M et al. Epidemic of liver disease caused by hydrochlorofluorocarbons used as ozone-sparing substitutes of chlorofluoro carbons. Lancet 1997 350 : 556 559.
36. Njoku DB, Mellerson JL, Talor MV et al. Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in the pathogenesis of idiosyncratic drug-induced hepatitis. Clin Vaccine Immunol 2006 13 : 258 265.
37. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monoxygenase. J Clin Invest 1991 88 : 1370 1378.
38. Yamamoto AM, Cresteil D, Homberg JC, Alvarez F. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and negative sera. Gastroenterology 1993 104 : 1762 1767.
39. Kerkar N, Choudhuri K, Ma Y et al. Cytochrome P4502D6193-212: A new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003 170 : 1481 1489.
40. Marceau G, Lapierre P, Beland K, Soudeyns H, Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: A case of molecular mimicry Hepatology 2005 42 : 675 682.
41. Kamar N, Selves J, Mansuy JM et al. Hepatitis E and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008 358 : 811 817.
42. Haagsma EB, van der Berg AP, Porte RJ et al. Chronic hepatitis E infection in liver transplant recipients. Liver Transpl 2008 14 : 547 553.